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Despite recent advances in our understanding of paediatric pain and its management, pain continues to be undertreated globally,
particularly in children and in low income countries. This article describes the development of a paediatric analgesia and sedation
protocol, tailored to the speciﬁc setting of the Medical Research Council (MRC) paediatric ward in the Gambia, West Africa.
An iterative process was used throughout development, with inputs from the medical literature, local providers, and pain experts,
incorporatedtoensureasafe,eﬀective,andlocallyappropriateprotocol.Wedemonstratethatevidence-basedpublishedguidelines,
can and should be adapted to allow for optimal pain management given the resources and capabilities of speciﬁc health care
settings. It is hoped that the process and protocol described here, will not only help to improve care on the MRC ward, but serve
as an example to others working toward improving pain management in similar health care settings.
1.Introduction
Despite signiﬁcant advances in our understanding of pae-
diatric pain and the publication of pain management
guidelines by several leading paediatric bodies in recent
years,multiplestudiesandreviewsshowthatpaininchildren
continuestobepoorlymanaged[1].AsMacLeanetal.(2007)
note, “there remains a gap between what we know to be
eﬀective, easily implemented pain management strategies,
and what is actually practiced” [2]. Given these ﬁndings
are based on their review of pain management practices in
a paediatric teaching hospital in a high income country, it
is perhaps not surprising this gap is larger in low income
countries where resources, in their broadest sense, are more
constrained.
Some barriers to managing a child’s pain are common to
a wide variety of health care settings, such as lack of provider
training in the recognition, assessment and management
of pain, and attitudes and beliefs regarding pain and its
management. Other barriers likely play a signiﬁcant role
mainly in low income countries where resources in terms of
manpower,equipment,andmedications,areinchronicshort
supply and must be balanced across the competing needs of
patients presenting to providers practicing in these settings.
Despite these issues, given the current state of knowledge
in this area, and the wide variety of options now available
for managing paediatric pain, many of these barriers can
be overcome through adaptation of published guidelines to
address the unique needs and barriers of speciﬁc health care
settings.
This paper describes the development of a paediatric
analgesia and sedation protocol, tailored to the speciﬁc
setting of the Medical Research Council (MRC) paediatric
ward in the Gambia, West Africa. Although a combined
paediatric and adult protocol was ultimately developed,
only the paediatric portion is reported here. For clarity
of presentation, the protocol development process will be
described in 3 steps. However, it is important to note, that an
iterative process was employed beginning with a recognized
needtoimprovepainmanagementexpressedbylocalclinical
staﬀ, and with feedback from local providers sought and
incorporated throughout the development process.2 International Journal of Pediatrics
2. Methods
2.1. Local Consultation and Capacity Assessment. As noted
above, protocol development began with an expressed desire
for a pain management protocol tailored to the MRC
paediatric ward, to facilitate eﬀorts by clinical staﬀ toward
improving pain management. As a ﬁrst step, key local
informants including the senior clinician of the hospital, the
matron, and another senior nurse, were interviewed to gain
a comprehensive understanding of the hospitals resources,
current practices and staﬀ level of training, medication avail-
ability, and cost implications. Two important considerations
emergedfromthisconsultationprocess,whichwereshortage
of airway support capabilities and limited staﬀ training in
pain assessment and monitoring.
To further assess the airway capabilities on the ward, a
survey of equipment was undertaken. During this process,
suﬃcient airway equipment was located to organize two
completeairwaykits,whichincludedoralairways,bag-valve-
masks, intubation medications and equipment. Discussions
with physician and nursing staﬀ, revealed both had little
training or experience in pain management. For this reason
it was felt that a more directive and structured protocol, with
astrongeducationalcomponenttoaccompanyrolloutofthe
protocol was needed.
2.2. Knowledge Gathering. T h es e c o n ds t e pi nd e v e l o p m e n t
of the protocol began with a review of published paediatric
analgesia and sedation guidelines, the evidence base for their
development where possible, and consultation with experts
in paediatric sedation and analgesia. As most published
guidelinesweredevelopedinandforhighincomehealthcare
settings, during the review process and again in consultation
with key local informants a list of issues relevant to paedi-
atric pain management on the MRC ward was identiﬁed.
Concerns were identiﬁed with respect to several unique
attributesoftheGambianpopulation,speciﬁcallytherelative
high prevalence of hemoglobinopathies [3, 4]a n du n d e r -
nutrition particularly in the ﬁrst 2 years of life [5]. It was
notablethatdespitetheimportanceofculturalinperceptions
and beliefs with respect to pain, no cultural issues were
identiﬁed as important to pain management eﬀorts in this
setting.
Hemoglobinopathies, like sickle cell anemia and glucose-
6-phosphatase deﬁciency (G6PD), are relatively common in
the Gambia [3, 4] and present challenges for managing pain.
Many established guidelines and experts recommend against
sedation in sickle disease patients, and sickle trait patients
with low oxygen saturations, unless anaesthesia is in atten-
dance.GivenanaesthesiasupportisnotavailableattheMRC,
thesewereincludedasabsolutecontraindicationstosedation
in the MRC protocol. Of additional concern is the potential
for local anaesthetic induced methemoglobinemia. For a
variety of reasons, including eﬀectiveness, hemodynamic
safety requiring no special monitoring, and availability of
inexpensive preparations, local anaesthetics are ideal for
management of brief painful procedures. While a variety
of local anaesthetics have been reported to induce methe-
moglobinemia [6], reported cases have occurred mainly in
very young infants or where excessive quantities of topical
anaesthetic are used [7]. Although an uncommon complica-
tion and relatively easily managed in the general population
with methylene blue, treatment of methemoglobinemia is
signiﬁcantly more complicated in individuals with G6PD
deﬁciency where methylene blue can cause acute hemolysis
and more intensive care, including exchange transfusions,
may be required. Given the high incidence of G6PD in the
Gambian population, cost and time required for testing,
and potential for this serious complication whose treatment
is beyond the resource capacity of the setting, use of
topical anaesthetics was strictly limited to children at least 6
months of age and within recommended dosing guidelines.
Guidelines and experts generally recommend 3 months of
age corrected for prematurity; however, given the prevalence
of under-nutrition and diﬃculties in accurately assessing
both age of gestation and date of birth in this setting, the
age restriction was broadened to ensure minimum safety
guidelines were observed.
2.3. Protocol Circulation and Feedback. Based on the ﬁndings
of the ﬁrst two stages of protocol development outlined
above, a draft protocol was created and circulated to
key local informants and an expert in paediatric pain
management for feedback and amendment. Perhaps not
surprising considering the iterative nature of the develop-
ment process, with the exception noted below, no major
changes were suggested. At this stage the draft appeared
as a numbered list of process steps with considerations
at each step outlined within the section. For example,
within the analgesia section, all available options were listed
with their indications, contraindications, and dosages. While
this format was modelled after other published protocols,
and meant to emphasize options and provider choice,
feedback from key local informants suggested that a more
limited and algorithmic approach, presented as a ﬂow
chart would facilitate adoption of the protocol, particularly
early on in the course of the campaign to improve pain
management.
Based on this feedback the protocol was reworked into
a ﬂow chart (see Figure 1), with the original protocol
with small amendments included as a detailed reference or
guide. The amended draft was again circulated to key local
informantsandthepainmanagementexpert,withnofurther
revisions suggested.
As a ﬁnal step in the development of the protocol,
the protocol was presented to the physician group at
academic rounds, and at a staﬀ meeting to the nursing and
health attendant staﬀ, with minor changes to the protocol
incorporated as a result of feedback from these sessions.
3. Results and Discussion
In addition to the ﬁnal product, that is, the paediatric
pain management protocol tailored to the MRC ward, other
beneﬁts were gained through the process of development. As
aresultoftheequipmentsurvey,twoairwaykitswerecreated
andplacedtogetherwithotherbasicresuscitationequipment
into a strategic location within the unit for ready access.International Journal of Pediatrics 3
Consult protocol for dosing,
and contraindications
Lower dose and monitor more
in liver and/or renal failure
What is needed?
Analgesia, sedation, both, nothing
Indication(s)–pain, anxiety, co-operation/safety
contraindication(s)–patient, procedure, personnel
For ketamine, remember pre-
medications to dry secretions,
prevent emergence, and
so forth ∗consult protocol
Analgesia Sedation PSA
Mild pain (1-2 faces, 1-4/10):
Non-pharmacologic
NSAID or paracetamol
Moderate pain (3-4 faces, 5-7/10)
Non-pharmacologic
Plus NSAID or paracetamol
Plus opioid (s/c or oral okay)
Severe/uncontrolled pain
Non-pharmacologic
Plus NSAID or paracetamol
Plus opioid (start iv if possible, convert
to po only once pain controlled)
Chronic/neurogenic pain
consider adjuvents and expect higher dose
requirement
Remember to treat nausea, prevent
constipation, treat depression if present
Acute anxiety
rarely indicated alone, consider if
patient so anxious/frightened they can
not participate in care/obey instructions
Consider
- nonpharmacologic approach
- low dose short acting benzodiazepine
(e.g. midazolam)
-R/O other causes
-Drug withdrawl or toxicity, and so forth
Assess response
Adequate Inadequate
Consider ongoing analgesic
Regular dose schedule plus breakthrough
Re-assess, add another agent, take action
D i dy o ut a k ec a u s eo fp a i n( s o m a t i c ,v i s c e r a l ,n e u r o g e n i c ) ,
duration of pain (acute, chronic),
patient characteristics, into account:
is something else needed (depression treatment, etc.)
Brief/minor painful procedure
E.g. IV insertion, Skin biopsy, lumbar puncture, thoracentesis,
paracentesis, and so forth
Topical local anaesthetic
Plus inﬁltration of local anaesthetic (LP, biopsy, etc.)
Plus mild sedation if very anxious (short acting benzo)
(∗keep within maximum local anaesthetic dose,
4mg/kg without epi, 7 with)
Moderate to severely painful procedure
E.g. bone marrow biopsy, chest tube insertion,
incision & drainage, burn dressing change
If no contra-indications → ketamine +/− adjuncts
child with contraindications to ketamine → short acting benzo
(e.g. midazolam) + short acting opiate (fentanyl)
(These procedures cause lasting pain, therefore
once awake begin regular pain medication(s))
Figure 1: Paediatric pain management ﬂow chart.
Equallyimportantisearlyevidencethatthroughtheedu-
cational and feedback sessions, further interest in improving
patient care was fostered among clinical staﬀ.A so n e
physicianreported“IencounteredacasetodaywhereIwould
normally not have considered pain management, but after
thesessiontheotherday,IdecidedIbetterdosomething.”As
Clemmer and Spuhler (1998) have argued, “the purpose of
creating protocols is greater than reducing practice variation,
it also creates new paradigms and changes the culture
in which health care is delivered, with the protocol itself
designed to be transient, and the development process and
the changes it produces, more important than the product
itself” [8]. It is hoped this was only the ﬁrst of many such
encounters.
However, to ensure successful implementation of the
protocol and ongoing improvements in paediatric pain
management, further steps are needed. Ongoing education
of clinical staﬀ, particularly early in the implementation
process and as new staﬀ are hired, is essential to ensure safe
and appropriate pain management procedures. Intermittent
reassessment and revision based on experiences in using the
protocol is needed to allow for adaptation as the needs of
the patients served and the resources and options available
change.
4. Conclusion
Despite some progress in recent years, pain continues
to be undertreated globally, particularly in children [1],
and particularly in low income countries [9]. Published
guidelines based on best available evidence, can and should
be adapted to allow for optimal pain management given
the resources and capabilities of a given health care setting.
It is hoped that the development process and protocol
described here will not only help to improve care on the
MRC ward, but serve as an example to others working
toward improving pain management in similar health care
settings.
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